Dr. Wang obtained her PhD degree in Microbiology at National Taiwan University. The main project was to investigate the Hepatitis C virus RNA regulating its replication via utilizing cellular protein for RNA circulation. 

Her postdoc experience was completed in University of Southern California, Institute of Molecular Microbiology and Immunology. Dr. Wang continued to study the intracellular membrane system that supports Hepatitis C virus RNA replication. Currently, she joined a startup company, AbVision Inc. The job duty includes therapeutic antibody discovery, production, and characterization.